PR Newswire12.06.21
OMRON Healthcare began a strategic partnership with Doctor Anywhere (DA), a regional omnichannel healthcare platform that provides a holistic range of health and wellness services. This collaboration will see the integration of OMRON's suite of smart health monitoring devices with DA's telehealth platform.
This will strengthen OMRON's contribution towards helping people in Southeast Asia lead healthier lifestyles, by inching closer to their vision of "Going For Zero" (heart attacks and strokes)—the elimination of preventable heart attacks and strokes via utilization of remote and telehealth domains.
In this collaboration, OMRON will integrate the health records tracked on its connected devices (OMRON Smart Elite BP Monitor HEM-7600T, OMRON Afib Blood Pressure Monitor HEM-7361T and OMRON Connected Wrist Blood Pressure Monitor HEM-6232T) with the DA mobile app. Patients with lifestyle diseases (such as hypertension, obesity, diabetes and cardiovascular diseases) can seamlessly share their health records in real time with healthcare professionals on the DA platform.
This will allow doctors to have timely and accurate access to patients' health records, to provide the best treatment options to manage their health condition efficiently. OMRON users with a need for long term disease management can also use the DA app to consult a doctor anytime, and get medication delivered to their home within three hours; delivery is free. The initiative is available to DA users in Singapore and will eventually be extended to DA's database of 2.5 million users across Southeast Asia (Singapore, Malaysia, Thailand, Vietnam, and the Philippines).
OMRON Afib Blood Pressure Monitor HEM-7361T.
With the launch of the connected series supported by the OMRON Connect App, users can synchronize and store their blood pressure and heart rate readings in-app, for convenient real time access by their doctors.
According to Alexis En, Director of Marketing at OMRON Healthcare Singapore Pte Ltd, "Keeping in sync with the changing times and the pressing need to enhance the reach of home-based health monitoring in the new normal, OMRON Healthcare aims to enhance its value in the telehealth and remote patient monitoring domain. We are glad to partner with progressive organizations like Doctor Anywhere. Our synergies in technology will surely help us create a better and healthier society in South-East Asia."
Ivin Yew, Director of Transformation and Innovation of Doctor Anywhere, said, "Innovation is at the heart of everything we do. As we continue to push the boundaries by revolutionising the healthcare experience through innovation and technology, we are heartened by the invaluable support and trust by OMRON, a global leader in the domain of innovative healthcare devices."
Based on the recent statistics from World Health Organisation (WHO), the number of deaths from cardiovascular diseases is on the rise, with more than 12.6 million cases in 2015 and 17.9 million cases in 2019, representing 32 percent of global deaths. There are several underlying causes such as high blood pressure, high cholesterol levels, raised blood glucose and weight issues. Also, reports highlight that hypertension is one of the most powerful modifiable risk factors for cardiovascular disease; lowering blood pressure substantially reduces the risk of cardiovascular morbidity and mortality.
However, it continues to pose a significant burden in Asia, with poor awareness and undertreatment reported in many Asian countries and regions. It's estimated to cause nearly 1.5 million of deaths each year in Southeast Asia. Considering the asymptomatic nature of hypertension and the significant disease burden, it is essential to measure blood pressure regularly. Home blood pressure monitoring (HBPM) is recognized as a valuable tool to monitor blood pressure and facilitate effective detection of hypertension. Combined with right drugs treatment, it can play a significant role in reducing cardiovascular risk and prevent heart attacks and strokes among people with these conditions.
This will strengthen OMRON's contribution towards helping people in Southeast Asia lead healthier lifestyles, by inching closer to their vision of "Going For Zero" (heart attacks and strokes)—the elimination of preventable heart attacks and strokes via utilization of remote and telehealth domains.
In this collaboration, OMRON will integrate the health records tracked on its connected devices (OMRON Smart Elite BP Monitor HEM-7600T, OMRON Afib Blood Pressure Monitor HEM-7361T and OMRON Connected Wrist Blood Pressure Monitor HEM-6232T) with the DA mobile app. Patients with lifestyle diseases (such as hypertension, obesity, diabetes and cardiovascular diseases) can seamlessly share their health records in real time with healthcare professionals on the DA platform.
This will allow doctors to have timely and accurate access to patients' health records, to provide the best treatment options to manage their health condition efficiently. OMRON users with a need for long term disease management can also use the DA app to consult a doctor anytime, and get medication delivered to their home within three hours; delivery is free. The initiative is available to DA users in Singapore and will eventually be extended to DA's database of 2.5 million users across Southeast Asia (Singapore, Malaysia, Thailand, Vietnam, and the Philippines).
OMRON Afib Blood Pressure Monitor HEM-7361T.
According to Alexis En, Director of Marketing at OMRON Healthcare Singapore Pte Ltd, "Keeping in sync with the changing times and the pressing need to enhance the reach of home-based health monitoring in the new normal, OMRON Healthcare aims to enhance its value in the telehealth and remote patient monitoring domain. We are glad to partner with progressive organizations like Doctor Anywhere. Our synergies in technology will surely help us create a better and healthier society in South-East Asia."
Ivin Yew, Director of Transformation and Innovation of Doctor Anywhere, said, "Innovation is at the heart of everything we do. As we continue to push the boundaries by revolutionising the healthcare experience through innovation and technology, we are heartened by the invaluable support and trust by OMRON, a global leader in the domain of innovative healthcare devices."
Based on the recent statistics from World Health Organisation (WHO), the number of deaths from cardiovascular diseases is on the rise, with more than 12.6 million cases in 2015 and 17.9 million cases in 2019, representing 32 percent of global deaths. There are several underlying causes such as high blood pressure, high cholesterol levels, raised blood glucose and weight issues. Also, reports highlight that hypertension is one of the most powerful modifiable risk factors for cardiovascular disease; lowering blood pressure substantially reduces the risk of cardiovascular morbidity and mortality.
However, it continues to pose a significant burden in Asia, with poor awareness and undertreatment reported in many Asian countries and regions. It's estimated to cause nearly 1.5 million of deaths each year in Southeast Asia. Considering the asymptomatic nature of hypertension and the significant disease burden, it is essential to measure blood pressure regularly. Home blood pressure monitoring (HBPM) is recognized as a valuable tool to monitor blood pressure and facilitate effective detection of hypertension. Combined with right drugs treatment, it can play a significant role in reducing cardiovascular risk and prevent heart attacks and strokes among people with these conditions.
